Holen Sie sich die Stockscreener-App
5.99
5.58%
0.34
Handel nachbörslich:
5.90
-0.09
-1.50%
Schlusskurs vom Vortag:
$5.65
Offen:
$5.48
24-Stunden-Volumen:
4.31M
Relative Volume:
1.12
Marktkapitalisierung:
$806.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-217.44M
KGV:
-2.7604
EPS:
-2.17
Netto-Cashflow:
$-205.20M
1W Leistung:
+1.62%
1M Leistung:
+46.56%
6M Leistung:
+348.50%
1J Leistung:
+59.92%
1-Tages-Spanne:
$5.25
$6.105
1-Wochen-Bereich:
$5.25
$6.85
52-Wochen-Spanne:
$1.11
$6.94
Prime Medicine Inc Stock (PRME) Company Profile
Firmenname
Prime Medicine Inc
Sektor
Branche
Telefon
617-465-0013
Adresse
60 FIRST ST., CAMBRIDGE
Vergleichen Sie PRME mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRME
Prime Medicine Inc
|
5.99 | 1.01B | 0 | -217.44M | -205.20M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Prime Medicine Inc Stock (PRME) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-27 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-20 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-05-20 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-12-10 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-16 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-22 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-04-08 | Eingeleitet | TD Cowen | Buy |
| 2024-04-03 | Eingeleitet | Wedbush | Outperform |
| 2024-01-16 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-08 | Eingeleitet | Citigroup | Neutral |
| 2023-10-09 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-07-31 | Eingeleitet | Guggenheim | Buy |
| 2023-04-18 | Eingeleitet | Stifel | Buy |
| 2022-11-14 | Eingeleitet | Goldman | Neutral |
| 2022-11-14 | Eingeleitet | JP Morgan | Overweight |
| 2022-11-14 | Eingeleitet | Jefferies | Buy |
| 2022-11-14 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Prime Medicine Inc Aktie (PRME) Neueste Nachrichten
Quantitative breakdown of Prime Medicine Inc. recent moveTrade Entry Report & Weekly Momentum Picks - newser.com
Why Prime Medicine Inc. stock appeals to analysts2025 Year in Review & Consistent Profit Focused Trading Strategies - newser.com
Painful Week for Retail Investors Invested in Prime Medicine, Inc. (NASDAQ:PRME) After 6.6% Drop, Institutions Also Suffered Losses - 富途牛牛
Does Prime Medicine Inc. qualify in momentum factor screeningQuarterly Portfolio Report & Growth Focused Entry Reports - newser.com
News impact scoring models applied to Prime Medicine Inc.Volume Spike & Free Risk Controlled Daily Trade Plans - newser.com
Trend analysis for Prime Medicine Inc. this weekMarket Activity Summary & Expert Verified Stock Movement Alerts - newser.com
Is Prime Medicine Inc. stock a buy on dips2025 Volatility Report & Weekly High Momentum Picks - newser.com
Prime Medicine, Inc.'s (NASDAQ:PRME) 6.6% loss last week hit both individual investors who own 30% as well as institutions - simplywall.st
Prime Medicine (NASDAQ:PRME) Stock Price Down 5.8%Here's What Happened - MarketBeat
Prime Medicine (NYSE:PRME) Stock Price Down 3.4%Here's What Happened - MarketBeat
Using AI based signals to follow Prime Medicine Inc.Market Growth Summary & Short-Term Trading Opportunity Alerts - newser.com
Is it too late to sell Prime Medicine Inc.July 2025 Short Interest & Short-Term High Return Strategies - newser.com
Prime Medicine Soars 9.88% to Day High of $6.85 Amid Strong Intraday Performance - Markets Mojo
Is Prime Medicine Inc. stock entering bullish territoryWeekly Stock Report & High Return Trade Guides - newser.com
How to recover losses in Prime Medicine Inc. stockMarket Risk Report & Daily Stock Momentum Reports - newser.com
Volume spikes in Prime Medicine Inc. stock – what they mean2025 Technical Patterns & Long-Term Safe Investment Plans - newser.com
Volatility clustering patterns for Prime Medicine Inc.July 2025 Fed Impact & Low Drawdown Investment Ideas - newser.com
Prime Medicine (NASDAQ:PRME) Stock Price Up 11.6%Should You Buy? - MarketBeat
Prime Medicine (NYSE:PRME) Shares Up 7.8%Still a Buy? - MarketBeat
Prime Medicine, Inc. Hits New 52-Week High of $6.94 - Markets Mojo
Prime Medicine, Inc. Hits New 52-Week High of $6.92 - Markets Mojo
Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewswire
Prime Medicine (NASDAQ:PRME) Sets New 12-Month HighWhat's Next? - MarketBeat
Prime Medicine, Inc. (NYSE:PRME) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
What earnings revisions data tells us about Prime Medicine Inc.July 2025 Patterns & Entry and Exit Point Strategies - newser.com
Published on: 2025-10-06 02:45:47 - newser.com
Using flow based indicators on Prime Medicine Inc.Quarterly Market Review & Momentum Based Trading Signals - newser.com
Measuring Prime Medicine Inc.’s beta against major indicesJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com
Prime Medicine Stock Price, Quotes and Forecasts | NASDAQ:PRME - Benzinga
Prime Medicine, Inc. Hits New 52-Week High of $5.82 - Markets Mojo
Short interest data insights for Prime Medicine Inc.July 2025 Trends & Stock Portfolio Risk Management - newser.com
Backtesting results for Prime Medicine Inc. trading strategiesJuly 2025 Volume & Smart Investment Allocation Insights - newser.com
Is Prime Medicine Inc a good long term investmentIPO Market Watch & Double Digit Wealth Tips - earlytimes.in
Prime Medicine (NYSE:PRME) Trading Up 8%What's Next? - MarketBeat
Prime Medicine Sees Strong Momentum Among Top Healthcare Stocks - Kalkine Media
Prime Medicine (NASDAQ:PRME) Hits New 1-Year HighTime to Buy? - MarketBeat
Prime Medicine (NASDAQ:PRME) Shares Up 3.9%Here's Why - MarketBeat
When is the best time to exit Prime Medicine Inc.July 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
Septerna appoints Keith Gottesdiener to board of directors - Investing.com India
Former Prime Medicine CEO and 20+ Drug Approval Leader Keith Gottesdiener Joins Septerna's Board - Stock Titan
Finanzdaten der Prime Medicine Inc-Aktie (PRME)
Umsatz
Nettogewinn
Free Cashflow
ENV
Prime Medicine Inc-Aktie (PRME) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| NELSEN ROBERT | Director |
Aug 01 '25 |
Buy |
3.30 |
3,030,300 |
9,999,990 |
6,230,300 |
| ARCH Venture Partners XII, LLC | 10% Owner |
Aug 01 '25 |
Buy |
3.30 |
3,030,300 |
9,999,990 |
6,230,300 |
| ARCH Venture Partners X, LLC | 10% Owner |
Aug 01 '25 |
Buy |
3.30 |
3,030,300 |
9,999,990 |
6,230,300 |
| Liu David R. | 10% Owner |
Jun 30 '25 |
Buy |
2.52 |
21,000 |
52,830 |
20,240,945 |
| Liu David R. | 10% Owner |
Jun 23 '25 |
Buy |
2.16 |
21,000 |
45,402 |
20,219,945 |
| Liu David R. | 10% Owner |
Jun 16 '25 |
Buy |
1.49 |
21,000 |
31,196 |
20,198,945 |
| Liu David R. | 10% Owner |
Jun 11 '25 |
Buy |
1.60 |
21,000 |
33,590 |
20,177,945 |
| Brudnick Richard | Chief Business Officer |
May 20 '25 |
Buy |
1.19 |
20,000 |
23,790 |
20,000 |
| LEE ANN L. | Chief Technical Officer |
May 21 '25 |
Buy |
1.13 |
100,000 |
113,000 |
100,000 |
| Reine Allan | Chief Executive Officer |
May 21 '25 |
Buy |
1.18 |
125,000 |
147,150 |
125,000 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):